Samil Pharmaceutical Co.,Ltd (KRX: 000520)

Samil Pharmaceutical Co.,Ltd Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	272,950	96,901	108,894	106,418	128,907	128,479
Market Cap Growth	51.37%	-11.01%	2.33%	-17.45%	0.33%	2.18%
Enterprise Value	413,490	272,367	265,842	202,048	200,995	180,425
Last Close Price	12900.00	6700.00	7800.00	7509.09	9184.43	9316.22
PE Ratio	-	58.26	-	-	92.12	159.12
PS Ratio	0.95	0.49	0.61	0.79	1.05	1.06
PB Ratio	1.53	0.76	0.87	1.62	2.03	2.06
P/TBV Ratio	0.99	0.77	0.89	1.65	2.09	2.12
P/OCF Ratio	11.15	8.25	26.21	75.11	16.58	12.13
EV/Sales Ratio	1.96	1.39	1.48	1.51	1.63	1.49
EV/EBITDA Ratio	35.37	23.03	29.52	39.53	18.72	20.48
EV/EBIT Ratio	66.02	42.16	66.19	505.45	30.74	37.62
EV/FCF Ratio	-53.43	-	-	-	-	-
Debt / Equity Ratio	0.82	1.38	1.27	1.91	1.49	1.50
Debt / EBITDA Ratio	12.19	14.87	17.68	24.55	8.79	10.63
Asset Turnover	0.56	0.54	0.62	0.64	0.66	0.73
Inventory Turnover	4.04	4.27	4.59	3.53	3.18	3.21
Quick Ratio	0.35	0.22	0.27	0.38	0.48	0.82
Current Ratio	0.74	0.48	0.56	0.63	0.73	1.16
Return on Equity (ROE)	-0.75%	1.31%	-0.03%	-8.27%	2.13%	1.33%
Return on Assets (ROA)	1.04%	1.11%	0.86%	0.12%	2.18%	1.81%
Return on Capital (ROIC)	1.27%	1.37%	1.05%	0.14%	2.60%	2.15%
Earnings Yield	-0.58%	1.72%	-0.03%	-5.02%	1.04%	0.61%
FCF Yield	-2.84%	-12.90%	-40.71%	-29.52%	-7.17%	-2.57%
Dividend Yield	0.00%	-	-	-	0.74%	0.73%
Payout Ratio	0.00%	-	-	-	68.55%	77.63%
Buyback Yield / Dilution	6.94%	-3.42%	-0.82%	-2.85%	-0.13%	-15.56%
Total Shareholder Return	6.94%	-3.42%	-0.82%	-2.85%	0.62%	-14.83%

Source: S&P Capital IQ. Standard template. Financial Sources.